Collaborating State Agencies definition

Collaborating State Agencies. [shall refer to means] the Delaware Office of Management and Budget, State Employee Benefits Committee, Division of Public Health, and Division of Medicaid and Medical Assistance and their successors, if applicable.
Sample 1Sample 2
Collaborating State Agencies means the Delaware Office of Management and Budget, State Employee Benefits Committee, Division of Public Health, Division of Medicaid and Medical Assistance, and their successors, if applicable any other agencies identified in 16 Del.C. §10314(c).
Sample 1

Examples of Collaborating State Agencies in a sentence

  • The DHIN and Collaborating State Agencies may issue public reports with aggregated HCCD data that adhere to the re-disclosure requirements without Committee review and approval.

  • The allowable uses of Claims Data by Collaborating State Agencies will be posted on DHIN’s web site for public transparency.

  • Nothing in this regulation precludes DHIN from charging reasonable fees to state agencies, including Collaborating State Agencies, for analytic services and data access beyond the standard data sets reported by the HCCD.

  • Exceptions to this rule include:3.4.1 Requests from Reporting Entities for their own data will not require Committee review.3.4.2 Collaborating State Agencies may access HCCD data without Committee review by entering into an interagency agreement with the DHIN.

  • DHIN shall provide Collaborating State Agencies with access, at no cost, to claims data reported by the HCCD.

  • HCCD data and data access will always be provided free of charge to the following entities: DHIN shall provide Collaborating State Agencies with access, at no cost, to claims data reported by the HCCD.

Related to Collaborating State Agencies

  • State agencies means all departments,

  • Contracting State means a State party to the Treaty;

  • Initiating state means a state in which a proceeding pursuant to this or a substantially similar reciprocal law is commenced.

  • Originating state means a state (and the subdivision thereof, if any) whose determination that certain educational personnel are qualified to be employed for specific duties in schools is acceptable in accordance with the terms of a contract made pursuant to article 3.

  • Third Party Applications means online, Web-based applications and offline software products that are provided by third parties and are identified as third-party applications, including but not limited to those listed on the AppExchange and the Reseller Application.

  • Collaborating physician means the physician who,

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • State agency means any of the principal departments in the Executive Branch of the State Government, and any division, board, bureau, office, commission or other instrumentality within or created by such department, the Legislature of the State and any office, board, bureau or commission within or created by the Legislative Branch, and any independent State authority, commission, instrumentality or agency.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • FDA means the United States Food and Drug Administration.

  • contracting authorities means the State, regional or local authorities, bodies governed by public law or associations formed by one or more such authorities or one or more such bodies governed by public law;

  • Licensing state means any state with regulations equivalent to the suggested state regulations for control of radiation relating to, and an effective program for, the regulatory control of NARM and which has been granted final designation by the Conference of Radiation Control Program Directors, Inc.

  • Commercial Product means any such product as defined in FAR 2.101.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • State Contracting Agency means the department for which this contract is to be performed and for which the Commissioner or Authorized Designee acted in signing this contract.

  • Commercial Production means the operation of the Property or any portion thereof as a producing mine and the production of mineral products therefrom (excluding bulk sampling, pilot plant or test operations);

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Collaborative lawyer means a lawyer who represents a party in a collaborative law process.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.

  • Commercial applicator means any person, unless exempted in I(4) hereunder, whether or not the person is a private applicator with respect to some uses, who:

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Commencement of Commercial Production means the first occurrence of Commercial Production in an Area.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.